tobramycin has been researched along with prednisolone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Davis, SD; Hyndiuk, RA; Sarff, LD | 1 |
| Gritz, DC; Kwitko, S; Lee, TY; McDonnell, PJ | 1 |
| Pallister, CJ; Warnock, DW | 1 |
| Callegan, MC; Engel, LS; Hill, JM; Hobden, JA; O'Callaghan, RJ; Reidy, JJ | 1 |
| Davydova, VA; Ismagilova, AF; Zarudiĭ, FS | 1 |
| Campbell, I; Herzig, S; Rootman, DS; Suresh, PS | 1 |
| Altin, F; Arslan, MO; Cinhüseyinoglue, F; Yalçin, E | 1 |
| Fleiszig, SM; Lee, EJ; Mendoza, MN; Truong, TN | 1 |
| Akova, YA; Gedik, S; Gür, S | 1 |
| Balzli, CL; Caballero, AR; McCormick, CC; O'Callaghan, RJ; Tang, A | 1 |
1 trial(s) available for tobramycin and prednisolone
| Article | Year |
|---|---|
N-acetylcysteine in chronic blepharitis.
Topics: Acetylcysteine; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Blepharitis; Chronic Disease; Female; Fluorophotometry; Glucocorticoids; Humans; Male; Mucins; Prednisolone; Prospective Studies; Tears; Tobramycin | 2002 |
13 other study(ies) available for tobramycin and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carbenicillin; Guinea Pigs; Injections, Intramuscular; Keratitis; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1978 |
Topical anti-inflammatory agents in an animal model of microbial keratitis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Flurbiprofen; Keratitis; Pharmaceutical Vehicles; Pneumococcal Infections; Prednisolone; Pseudomonas Infections; Rabbits; Tobramycin | 1990 |
Effect of antimicrobial and antineoplastic drugs alone and in combination on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.
Topics: Amphotericin B; Anti-Bacterial Agents; Antineoplastic Agents; Candida albicans; Cefuroxime; Ketoconazole; Methotrexate; Neutrophils; Phagocytosis; Prednisolone; Tobramycin; Vinblastine | 1989 |
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Keratitis; Ophthalmic Solutions; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1995 |
[Effect of 2-methyl-4-amino-6-hydroxypyrimidine on the effectiveness of antibiotic therapy in experimental staphylococcal infection in the context of immunosuppression].
Topics: Animals; Anti-Bacterial Agents; Azathioprine; Drug Synergism; Immunosuppressive Agents; Longevity; Mice; Prednisolone; Pyrimidines; Staphylococcal Infections; Survival Rate; Tobramycin | 1996 |
Mycobacterium keratitis following hyperopic laser in situ keratomileusis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cornea; Drug Resistance, Microbial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Hyperopia; Keratitis; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prednisolone; Tobramycin | 2001 |
A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Mice; Mice, Inbred C57BL; Ofloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis.
Topics: Anti-Bacterial Agents; Cefazolin; Child; Conjunctivitis, Allergic; Corneal Ulcer; Cyclopentolate; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Oxamic Acid; Prednisolone; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2006 |
The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Polysaccharides, Bacterial; Prednisolone; Pseudomonas Infections; Rabbits; Tobramycin | 2010 |